Seligson, N. D., Stets, C. W., Demoret, B. W., Awasthi, A., Grosenbacher, N., Shakya, R., … Chen, J. L. (2019). Inhibition of histone deacetylase 2 reduces MDM2 expression and reduces tumor growth in dedifferentiated liposarcoma. Oncotarget, 10(55), 5671–5679. https://doi.org/10.18632/oncotarget.27144

Seligson, Nathan D., Colin W. Stets, Bryce W. Demoret, Achal Awasthi, Nicholas Grosenbacher, Reena Shakya, John L. Hays, and James L. Chen. “Inhibition of histone deacetylase 2 reduces MDM2 expression and reduces tumor growth in dedifferentiated liposarcoma.” Oncotarget 10, no. 55 (October 1, 2019): 5671–79. https://doi.org/10.18632/oncotarget.27144.

Seligson ND, Stets CW, Demoret BW, Awasthi A, Grosenbacher N, Shakya R, et al. Inhibition of histone deacetylase 2 reduces MDM2 expression and reduces tumor growth in dedifferentiated liposarcoma. Oncotarget. 2019 Oct 1;10(55):5671–9.

Seligson, Nathan D., et al. “Inhibition of histone deacetylase 2 reduces MDM2 expression and reduces tumor growth in dedifferentiated liposarcoma.” Oncotarget, vol. 10, no. 55, Impact Journals, LLC, Oct. 2019, pp. 5671–79. Crossref, doi:10.18632/oncotarget.27144.

Seligson ND, Stets CW, Demoret BW, Awasthi A, Grosenbacher N, Shakya R, Hays JL, Chen JL. Inhibition of histone deacetylase 2 reduces MDM2 expression and reduces tumor growth in dedifferentiated liposarcoma. Oncotarget. Impact Journals, LLC; 2019 Oct 1;10(55):5671–5679.